Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiaan Remmers

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
BJU International|July 4, 2026
Cancer detection in the European Randomised Study of Screening for Prostate Cancer (ERSPC)Niko Pasanen, Kirsi Talala, Sebastiaan Remmers, et al.
Urology|July 8, 2022
Predictive Value of Cribriform and Intraductal Carcinoma for the Nomogram-based Selection of Prostate Cancer Patients for Pelvic Lymph Node DissectionHilda A de Barros, Sebastiaan Remmers, Henk B Luiting, et al.
European Urology Open Science|April 8, 2024
How Can We Improve Patient-Clinician Communication for Men Diagnosed with Prostate Cancer?Katharina Beyer, Ailbhe Lawlor, Sebastiaan Remmers, et al.
European Urology Open Science|July 11, 2022
Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 InitiativeSebastiaan Remmers, Jozien Helleman, Daan Nieboer, et al.
Journal of Personalized Medicine|May 28, 2022
Secondary Treatment for Men with Localized Prostate Cancer: A Pooled Analysis of PRIAS and ERSPC-Rotterdam Data within the PIONEER Data PlatformKatharina Beyer, Vera Straten, Sebastiaan Remmers, et al.
European Urology|April 23, 2023
Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate CancerSebastiaan Remmers, Chris H Bangma, Rebecka A Godtman, et al.
Cells|November 26, 2022
Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor SignalingAnnelies Van Hemelryk, Ingrid Tomljanovic, Corrina M A de Ridder, et al.
BJU International|May 10, 2022
NeuroSAFE in radical prostatectomy increases the rate of nerve-sparing surgery without affecting oncological outcomeMargaretha A van der Slot, Michael A den Bakker, Tamara S C Tan, et al.
The New England Journal of Medicine|October 29, 2025
European Study of Prostate Cancer Screening - 23-Year Follow-upMonique J Roobol, Ivo I de Vos, Marianne Månsson, et al.
The Journal of Urology|November 18, 2020
Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography in the Evaluation of Initial Response in Candidates Who Underwent Salvage Radiation Therapy after Radical Prostatectomy for Prostate CancerDennie Meijer, Henk B Luiting, Pim J van Leeuwen, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
BJU International|July 4, 2026
Cancer detection in the European Randomised Study of Screening for Prostate Cancer (ERSPC)Niko Pasanen, Kirsi Talala, Sebastiaan Remmers, et al.
Urology|July 8, 2022
Predictive Value of Cribriform and Intraductal Carcinoma for the Nomogram-based Selection of Prostate Cancer Patients for Pelvic Lymph Node DissectionHilda A de Barros, Sebastiaan Remmers, Henk B Luiting, et al.
European Urology Open Science|April 8, 2024
How Can We Improve Patient-Clinician Communication for Men Diagnosed with Prostate Cancer?Katharina Beyer, Ailbhe Lawlor, Sebastiaan Remmers, et al.
European Urology Open Science|July 11, 2022
Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 InitiativeSebastiaan Remmers, Jozien Helleman, Daan Nieboer, et al.
Journal of Personalized Medicine|May 28, 2022
Secondary Treatment for Men with Localized Prostate Cancer: A Pooled Analysis of PRIAS and ERSPC-Rotterdam Data within the PIONEER Data PlatformKatharina Beyer, Vera Straten, Sebastiaan Remmers, et al.
European Urology|April 23, 2023
Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate CancerSebastiaan Remmers, Chris H Bangma, Rebecka A Godtman, et al.
Cells|November 26, 2022
Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor SignalingAnnelies Van Hemelryk, Ingrid Tomljanovic, Corrina M A de Ridder, et al.
BJU International|May 10, 2022
NeuroSAFE in radical prostatectomy increases the rate of nerve-sparing surgery without affecting oncological outcomeMargaretha A van der Slot, Michael A den Bakker, Tamara S C Tan, et al.
The New England Journal of Medicine|October 29, 2025
European Study of Prostate Cancer Screening - 23-Year Follow-upMonique J Roobol, Ivo I de Vos, Marianne Månsson, et al.
The Journal of Urology|November 18, 2020
Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography in the Evaluation of Initial Response in Candidates Who Underwent Salvage Radiation Therapy after Radical Prostatectomy for Prostate CancerDennie Meijer, Henk B Luiting, Pim J van Leeuwen, et al.
Pageof 10